| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |